Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Diuretic Strategies in Heart Failure (3T Trial)
NCT02606253Phase 4Completed
- Sponsor
- Vanderbilt University
- Start
- Feb 2016
- Primary completion
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of tolvaptan in heart failure (HF), sponsored by Vanderbilt University. Primary endpoint: Weight Change Over 48 Hours. Started Feb 2016; status: completed.
02
Drugs
tolvaptan
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT02606253.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02606253.